Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1260

1.

PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized with Heart Failure.

Sayeed S, Fudim M, DeVore AD, Xu H, Matsouaka RA, Heidenreich PA, Yancy CW, Fonarow GC, Hernandez AF.

J Card Fail. 2019 Oct 15. pii: S1071-9164(19)30724-9. doi: 10.1016/j.cardfail.2019.10.003. [Epub ahead of print] No abstract available.

PMID:
31626949
2.

Association of Hospital Racial Composition and Payer Mix With Mortality in Acute Coronary Syndrome.

Srivastava PK, Fonarow GC, Bahiru E, Ziaeian B.

J Am Heart Assoc. 2019 Nov 5;8(21):e012831. doi: 10.1161/JAHA.119.012831. Epub 2019 Oct 18.

PMID:
31623505
3.

Heart Failure Self-care Associated With Brain Injury in Executive Control Regions.

Choi S, Roy B, Kumar R, Fonarow GC, Woo MA.

J Cardiovasc Nurs. 2019 Nov/Dec;34(6):433-439. doi: 10.1097/JCN.0000000000000611.

PMID:
31609280
4.

Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF.

Greene SJ, DeVore AD, Sheng S, Fonarow GC, Butler J, Califf RM, Hernandez AF, Matsouaka RA, Samman Tahhan A, Thomas KL, Vaduganathan M, Yancy CW, Peterson ED, O'Connor CM, Mentz RJ.

JACC Heart Fail. 2019 Oct 5. pii: S2213-1779(19)30664-X. doi: 10.1016/j.jchf.2019.07.011. [Epub ahead of print]

PMID:
31606362
5.

The Hospital Readmissions Reduction Program: Nationwide Perspectives and Recommendations.

Psotka MA, Fonarow GC, Allen LA, Joynt Maddox KE, Fiuzat M, Heidenreich P, Hernandez AF, Konstam MA, Yancy CW, O'Connor CM.

JACC Heart Fail. 2019 Oct 5. pii: S2213-1779(19)30675-4. doi: 10.1016/j.jchf.2019.07.012. [Epub ahead of print] Review.

PMID:
31606360
6.

Trends in Aggregate Use and Associated Expenditures of Antihyperglycemic Therapies Among US Medicare Beneficiaries Between 2012 and 2017.

Sumarsono A, Everett BM, McGuire DK, Fonarow GC, Butler J, Pandey A, Vaduganathan M.

JAMA Intern Med. 2019 Sep 30. doi: 10.1001/jamainternmed.2019.3884. [Epub ahead of print] No abstract available.

PMID:
31566649
7.

Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week.

Ball S, Ghosh RK, Wongsaengsak S, Bandyopadhyay D, Ghosh GC, Aronow WS, Fonarow GC, Lenihan DJ, Bhatt DL.

J Am Coll Cardiol. 2019 Oct 1;74(13):1714-1727. doi: 10.1016/j.jacc.2019.07.079. Review.

PMID:
31558256
8.

Readmissions After Acute Myocardial Infarction: How Often Do Patients Return to the Discharging Hospital?

Rymer JA, Chen AY, Thomas L, Fonarow GC, Peterson ED, Wang TY.

J Am Heart Assoc. 2019 Oct;8(19):e012059. doi: 10.1161/JAHA.119.012059. Epub 2019 Sep 20.

9.

Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection Fraction.

Khariton Y, Fonarow GC, Arnold SV, Hellkamp A, Nassif ME, Sharma PP, Butler J, Thomas L, Duffy CI, DeVore AD, Albert NM, Patterson JH, Williams FB, McCague K, Spertus JA.

JACC Heart Fail. 2019 Sep 7. pii: S2213-1779(19)30486-X. doi: 10.1016/j.jchf.2019.05.016. [Epub ahead of print]

PMID:
31521679
10.

Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score.

Segar MW, Vaduganathan M, Patel KV, McGuire DK, Butler J, Fonarow GC, Basit M, Kannan V, Grodin JL, Everett B, Willett D, Berry J, Pandey A.

Diabetes Care. 2019 Sep 13. pii: dc190587. doi: 10.2337/dc19-0587. [Epub ahead of print]

PMID:
31519694
11.

Reply: Titration of Guideline-Directed Medical Therapy Improves Patient-Centered Outcomes in Heart Failure With Reduced Ejection Fraction.

Greene SJ, Fonarow GC, Butler J.

J Am Coll Cardiol. 2019 Sep 10;74(10):1426-1427. doi: 10.1016/j.jacc.2019.06.061. No abstract available.

PMID:
31488284
12.

The Medicare Shared Savings Program and Outcomes for Ischemic Stroke Patients: a Retrospective Cohort Study.

Kaufman BG, O'Brien EC, Stearns SC, Matsouaka R, Holmes GM, Weinberger M, Song PH, Schwamm LH, Smith EE, Fonarow GC, Xian Y.

J Gen Intern Med. 2019 Aug 26. doi: 10.1007/s11606-019-05283-1. [Epub ahead of print]

PMID:
31452032
13.

Intravenous Tissue Plasminogen Activator in Stroke Mimics.

Ali-Ahmed F, Federspiel JJ, Liang L, Xu H, Sevilis T, Hernandez AF, Kosinski AS, Prvu Bettger J, Smith EE, Bhatt DL, Schwamm LH, Fonarow GC, Peterson ED, Xian Y.

Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005609. doi: 10.1161/CIRCOUTCOMES.119.005609. Epub 2019 Aug 15.

PMID:
31412730
14.

The Changing Landscape of Aortic Valve Replacement in the United States.

Gupta T, Kolte D, Khera S, Goel K, Villablanca PA, Kalra A, Abbott JD, Elmariah S, Fonarow GC, Rihal CS, Garcia MJ, Weisz G, Bhatt DL.

EuroIntervention. 2019 Aug 13. pii: EIJ-D-19-00381. doi: 10.4244/EIJ-D-19-00381. [Epub ahead of print]

15.

Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial.

Lam PH, Packer M, Fonarow GC, Faselis C, Allman RM, Morgan CJ, Singh S, Pitt B, Ahmed A.

Am J Med. 2019 Aug 8. pii: S0002-9343(19)30615-1. doi: 10.1016/j.amjmed.2019.06.053. [Epub ahead of print]

PMID:
31401165
16.

Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.

Malik A, Masson R, Singh S, Wu WC, Packer M, Pitt B, Waagstein F, Morgan CJ, Allman RM, Fonarow GC, Ahmed A.

J Am Coll Cardiol. 2019 Aug 6;74(5):617-627. doi: 10.1016/j.jacc.2019.05.064.

PMID:
31370952
17.

Body mass index and outcomes of cardiac resynchronization with implantable cardioverter-defibrillator therapy in older patients with heart failure.

Echouffo-Tcheugui JB, Masoudi FA, Bao H, Curtis JP, Heidenreich PA, Fonarow GC.

Eur J Heart Fail. 2019 Sep;21(9):1093-1102. doi: 10.1002/ejhf.1552. Epub 2019 Jul 29.

PMID:
31359595
18.

Regional Differences in Secondary Prevention Therapy-Geography Should Not Be Destiny.

Navar AM, Fonarow GC.

JAMA Cardiol. 2019 Jul 24. doi: 10.1001/jamacardio.2019.2548. [Epub ahead of print] No abstract available.

PMID:
31339523
19.

Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction.

Malik A, Gill GS, Lodhi FK, Tummala LS, Singh SN, Morgan CJ, Allman RM, Fonarow GC, Ahmed A.

Am J Med. 2019 Jul 20. pii: S0002-9343(19)30581-9. doi: 10.1016/j.amjmed.2019.06.040. [Epub ahead of print]

PMID:
31336093
20.

Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke: Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study.

Xian Y, Xu H, O'Brien EC, Shah S, Thomas L, Pencina MJ, Fonarow GC, Olson DM, Schwamm LH, Bhatt DL, Smith EE, Hannah D, Maisch L, Lytle BL, Peterson ED, Hernandez AF.

JAMA Neurol. 2019 Jul 22. doi: 10.1001/jamaneurol.2019.2099. [Epub ahead of print]

PMID:
31329212
21.

Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy.

Inohara T, Liang L, Kosinski AS, Smith EE, Schwamm LH, Hernandez AF, Bhatt DL, Fonarow GC, Peterson ED, Xian Y.

J Am Heart Assoc. 2019 Aug 6;8(15):e012450. doi: 10.1161/JAHA.119.012450. Epub 2019 Jul 20.

22.

Hospital distance, socioeconomic status, and timely treatment of ischemic stroke.

Ader J, Wu J, Fonarow GC, Smith EE, Shah S, Xian Y, Bhatt DL, Schwamm LH, Reeves MJ, Matsouaka RA, Sheth KN.

Neurology. 2019 Aug 20;93(8):e747-e757. doi: 10.1212/WNL.0000000000007963. Epub 2019 Jul 18.

PMID:
31320472
23.

Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice.

Jahan R, Saver JL, Schwamm LH, Fonarow GC, Liang L, Matsouaka RA, Xian Y, Holmes DN, Peterson ED, Yavagal D, Smith EE.

JAMA. 2019 Jul 16;322(3):252-263. doi: 10.1001/jama.2019.8286.

PMID:
31310296
24.

Impediments to Implementing Guideline-Directed Medical Therapies.

Fonarow GC, Navar AM, Yancy CW.

JAMA Cardiol. 2019 Jul 10. doi: 10.1001/jamacardio.2019.2276. [Epub ahead of print] No abstract available.

PMID:
31290930
25.

Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.

Pokorney SD, Holmes DN, Thomas L, Fonarow GC, Kowey PR, Reiffel JA, Singer DE, Freeman JV, Gersh BJ, Mahaffey KW, Hylek EM, Naccarelli GV, Ezekowitz MD, Piccini JP, Peterson ED; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators.

JAMA Cardiol. 2019 Jul 3. doi: 10.1001/jamacardio.2019.1960. [Epub ahead of print]

26.

Aberrant Brain Functional Connectivity Dynamic Responses to the Valsalva Maneuver in Heart Failure.

Song X, Roy B, Lai M, Sahib A, Fonarow GC, Woo MA, Kumar R.

J Card Fail. 2019 Sep;25(9):757-766. doi: 10.1016/j.cardfail.2019.06.010. Epub 2019 Jun 29.

PMID:
31265919
27.

Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.

Arundel C, Lam PH, Gill GS, Patel S, Panjrath G, Faselis C, White M, Morgan CJ, Allman RM, Aronow WS, Singh SN, Fonarow GC, Ahmed A.

J Am Coll Cardiol. 2019 Jun 25;73(24):3054-3063. doi: 10.1016/j.jacc.2019.04.022.

PMID:
31221253
28.

Physicians Voluntarily Using an EHR-Based CDS Tool Improved Patients' Guideline-Related Statin Prescription Rates: A Retrospective Cohort Study.

Chang TS, Buchipudi A, Fonarow GC, Pfeffer MA, Singer JS, Cheng EM.

Appl Clin Inform. 2019 May;10(3):421-445. doi: 10.1055/s-0039-1692186. Epub 2019 Jun 19.

PMID:
31216590
29.

Cohort Study of Repeated Measurements of Serum Urate and Risk of Incident Atrial Fibrillation.

Li S, Cheng J, Cui L, Gurol ME, Bhatt DL, Fonarow GC, Benjamin EJ, Xing A, Xia Y, Wu S, Gao X.

J Am Heart Assoc. 2019 Jul 2;8(13):e012020. doi: 10.1161/JAHA.119.012020. Epub 2019 Jun 19.

30.

The Burden of Congestion in Patients Hospitalized With Acute Decompensated Heart Failure.

Cooper LB, Lippmann SJ, DiBello JR, Gorsh B, Curtis LH, Sikirica V, Hernandez AF, Sprecher DL, Laskey WK, Saini R, Fonarow GC, Hammill BG.

Am J Cardiol. 2019 Aug 15;124(4):545-553. doi: 10.1016/j.amjcard.2019.05.030. Epub 2019 May 25.

PMID:
31208702
31.

Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF.

Thomas M, Khariton Y, Fonarow GC, Arnold SV, Hill L, Nassif ME, Sharma PP, Butler J, Thomas L, Duffy CI, DeVore AD, Hernandez A, Albert NM, Patterson JH, Williams FB, McCague K, Spertus JA.

JACC Heart Fail. 2019 Jul;7(7):615-625. doi: 10.1016/j.jchf.2019.03.020. Epub 2019 Jun 5.

32.

Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular Disease.

Fonarow GC, van Hout B, Villa G, Arellano J, Lindgren P.

JAMA Cardiol. 2019 Jul 1;4(7):691-695. doi: 10.1001/jamacardio.2019.1647.

33.

Digoxin Use and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.

Qamer SZ, Malik A, Bayoumi E, Lam PH, Singh S, Packer M, Kanonidis IE, Morgan CJ, Abdelmawgoud A, Allman RM, Fonarow GC, Ahmed A.

Am J Med. 2019 May 29. pii: S0002-9343(19)30443-7. doi: 10.1016/j.amjmed.2019.05.012. [Epub ahead of print]

PMID:
31150644
34.

Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II.

Inohara T, Shrader P, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Go AS, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP; ORBIT AF Patients and Investigators.

Am Heart J. 2019 Jul;213:81-90. doi: 10.1016/j.ahj.2019.04.007. Epub 2019 Apr 24.

PMID:
31129441
35.

Longitudinal Trajectories of Hospital Performance across Targeted Cardiovascular Conditions in the United States.

Vaduganathan M, McCarthy CP, Ayers C, Bhatt DL, Kumbhani DJ, de Lemos JA, Fonarow GC, Pandey A.

Eur Heart J Qual Care Clin Outcomes. 2019 May 24. pii: qcz026. doi: 10.1093/ehjqcco/qcz026. [Epub ahead of print]

PMID:
31124567
36.

A paradoxical relationship between hemoglobin A1C and in-hospital mortality in intracerebral hemorrhage patients.

Dandapat S, Siddiqui FM, Fonarow GC, Bhatt DL, Xu H, Matsouaka R, Heidenreich PA, Xian Y, Schwamm LH, Smith EE.

Heliyon. 2019 May 6;5(5):e01659. doi: 10.1016/j.heliyon.2019.e01659. eCollection 2019 May.

37.

Thrombolysis in young adults with stroke: Findings from Get With The Guidelines-Stroke.

Dodds JA, Xian Y, Sheng S, Fonarow GC, Bhatt DL, Matsouaka R, Schwamm LH, Peterson ED, Smith EE.

Neurology. 2019 Jun 11;92(24):e2784-e2792. doi: 10.1212/WNL.0000000000007653. Epub 2019 May 15.

PMID:
31092622
38.

Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score.

Holmes DN, Piccini JP, Allen LA, Fonarow GC, Gersh BJ, Kowey PR, O'Brien EC, Reiffel JA, Naccarelli GV, Ezekowitz MD, Chan PS, Singer DE, Spertus JA, Peterson ED, Thomas L.

Circ Cardiovasc Qual Outcomes. 2019 May;12(5):e005358. doi: 10.1161/CIRCOUTCOMES.118.005358.

PMID:
31092022
39.

Cardiogenic shock during heart failure hospitalizations: Age-, sex-, and race-stratified trends in incidence and outcomes.

Yandrapalli S, Sanaani A, Harikrishnan P, Aronow WS, Frishman WH, Lanier GM, Ahmed A, Fonarow GC.

Am Heart J. 2019 Jul;213:18-29. doi: 10.1016/j.ahj.2019.03.015. Epub 2019 Apr 11.

PMID:
31078113
40.

Overcoming Barriers to Development of Novel Therapies for Cardiovascular Disease: Insights From the Oncology Drug Development Experience.

Khakoo AY, Yurgin NR, Eisenberg PR, Fonarow GC.

JACC Basic Transl Sci. 2019 Apr 29;4(2):269-274. doi: 10.1016/j.jacbts.2019.01.011. eCollection 2019 Apr.

41.

Prevalence of Apparent Treatment-Resistant Hypertension in the United States According to the 2017 High Blood Pressure Guideline.

Patel KV, Li X, Kondamudi N, Vaduganathan M, Adams-Huet B, Fonarow GC, Vongpatanasin W, Pandey A.

Mayo Clin Proc. 2019 May;94(5):776-782. doi: 10.1016/j.mayocp.2018.12.033.

PMID:
31054605
42.

Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients With History of Stroke Plus Diabetes Mellitus.

Ehrlich ME, Liang L, Xu H, Kosinski AS, Hernandez AF, Schwamm LH, Smith EE, Fonarow GC, Bhatt DL, Peterson ED, Xian Y.

Stroke. 2019 Jun;50(6):1497-1503. doi: 10.1161/STROKEAHA.118.024172. Epub 2019 Apr 30.

PMID:
31035901
43.

Corrigendum to `Trends in Utilization of Surgical and Transcatheter Mitral Valve Repair in the United States☆' [The American Journal of Cardiology 123/7 (2019) 1187-1189].

Gupta T, Khera S, Kolte D, Goel K, Villablanca PA, Abbott JD, Fonarow GC, Rihal CS, Garcia MJ, Bhatt DL, Latib A, Weisz G.

Am J Cardiol. 2019 Jul 1;124(1):168. doi: 10.1016/j.amjcard.2019.04.001. Epub 2019 Apr 26. No abstract available.

PMID:
31030968
44.

Association of the New Peer Group-Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program.

McCarthy CP, Vaduganathan M, Patel KV, Lalani HS, Ayers C, Bhatt DL, Januzzi JL Jr, de Lemos JA, Yancy C, Fonarow GC, Pandey A.

JAMA Netw Open. 2019 Apr 5;2(4):e192987. doi: 10.1001/jamanetworkopen.2019.2987.

45.

Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry.

Perino AC, Shrader P, Turakhia MP, Ansell JE, Gersh BJ, Fonarow GC, Go AS, Kaiser DW, Hylek EM, Kowey PR, Singer DE, Thomas L, Steinberg BA, Peterson ED, Piccini JP, Mahaffey KW.

J Am Heart Assoc. 2019 May 7;8(9):e011205. doi: 10.1161/JAHA.118.011205.

46.

Identifying a low-flow phenotype in heart failure with preserved ejection fraction: a secondary analysis of the RELAX trial.

Patel KV, Mauricio R, Grodin JL, Ayers C, Fonarow GC, Berry JD, Pandey A.

ESC Heart Fail. 2019 Aug;6(4):613-620. doi: 10.1002/ehf2.12431. Epub 2019 Apr 16.

47.

Prehospital statin use and low-density lipoprotein cholesterol levels at admission in acute coronary syndrome patients with history of myocardial infarction or revascularization: Findings from the Improving Care for Cardiovascular Disease in China (CCC) project.

Xing Y, Liu J, Hao Y, Liu J, Huo Y, Smith SC Jr, Ge J, Ma C, Han Y, Fonarow GC, Taubert KA, Morgan L, Yang N, Zhou M, Zhao D; CCC-ACS Investigators.

Am Heart J. 2019 Jun;212:120-128. doi: 10.1016/j.ahj.2019.02.019. Epub 2019 Mar 13.

PMID:
30986750
48.

Performance on management strategies with Class I Recommendation and A Level of Evidence among hospitalized patients with non-ST-segment elevation acute coronary syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) project.

Yang N, Liu J, Liu J, Hao Y, Huo Y, Smith SC Jr, Ge J, Ma C, Han Y, Fonarow GC, Taubert KA, Morgan L, Zhou M, Xing Y, Zhao D; CCC-ACS Investigators.

Am Heart J. 2019 Jun;212:80-90. doi: 10.1016/j.ahj.2019.02.012. Epub 2019 Mar 4.

PMID:
30981036
49.

Association of post-discharge specialty outpatient visits with readmissions and mortality in high-risk heart failure patients.

Edmonston DL, Wu J, Matsouaka RA, Yancy C, Heidenreich P, Piña IL, Hernandez A, Fonarow GC, DeVore AD.

Am Heart J. 2019 Jun;212:101-112. doi: 10.1016/j.ahj.2019.03.005. Epub 2019 Mar 21.

PMID:
30978555
50.

Home-time Is a Patient-Centered Outcome Variable for Stroke: An Executive Summary.

Shah S, Xian Y, Olson DM, Fonarow GC, Smith EE, Maisch L, O'Brien EC.

J Neurosci Nurs. 2019 Jun;51(3):110-112. doi: 10.1097/JNN.0000000000000437. No abstract available.

PMID:
30964840

Supplemental Content

Loading ...
Support Center